Skip to main content
logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
20.39
-0.43 (-2.07%)
Sep 23, 2026, 10:35 AM EDT - Market open

Latigo Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
5569.4417.92
Cash & Short-Term Investments
5569.4417.92
Cash Growth
-287.53%-
Prepaid Expenses
3.322.183.25
Restricted Cash
0.190.19-
Other Current Assets
0.682.02-
Total Current Assets
59.273.8321.16
Property, Plant & Equipment
1.761.071.41
Other Long-Term Assets
0.50.620.29
Total Assets
64.7675.5222.86

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
3.575.027.07
Accrued Expenses
12.2612.876.73
Current Portion of Leases
0.710.560.39
Other Current Liabilities
5.15-0.25
Total Current Liabilities
51.5818.4514.44
Long-Term Leases
0.650.130.46
Other Long-Term Liabilities
0.040.040.04
Total Liabilities
52.2618.6114.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
15.8111.464.37
Retained Earnings
-291.89-243.13-133.96
Total Common Equity
-276.08-231.67-129.6
Shareholders' Equity
12.556.917.93
Total Liabilities & Equity
64.7675.5222.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
31.250.690.85
Net Cash (Debt)
23.7568.7517.07
Net Cash Growth
-302.81%-
Net Cash Per Share
24.9581.3825.13
Filing Date Shares Outstanding
66.30.880.68
Total Common Shares Outstanding
0.990.880.68
Working Capital
7.6255.386.73
Book Value Per Share
-279.37-263.71-190.84
Tangible Book Value
-276.08-231.67-129.6
Tangible Book Value Per Share
-279.37-263.71-190.84
Machinery
1.41.31.26
SEC Filings: 10-K · 10-Q